A Case of Catatonia in a Man With COVID-19

Psychosomatics. 2020 Sep-Oct;61(5):556-560. doi: 10.1016/j.psym.2020.05.021. Epub 2020 May 27.

Authors

Marissa P Caan¹, Christopher T Lim², Mark Howard³

Affiliations

¹ Department of Psychiatry, Cambridge Health Alliance, Cambridge, MA; Harvard Medical School, Boston, MA. Electronic address: mcaan@challiance.org.
² Department of Psychiatry, Cambridge Health Alliance, Cambridge, MA; Harvard Medical School, Boston, MA.
³ Department of Psychiatry, Cambridge Health Alliance, Cambridge, MA.

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anti-Bacterial Agents / adverse effects
Azithromycin / adverse effects
Betacoronavirus
COVID-19
Catatonia / complications
Catatonia / drug therapy
Catatonia / physiopathology*
Catatonia / psychology
Coronavirus Infections / complications
Coronavirus Infections / drug therapy
Coronavirus Infections / physiopathology*
Coronavirus Infections / psychology
Delusions / complications
Delusions / drug therapy
Delusions / physiopathology*
Delusions / psychology
Hallucinations / complications
Hallucinations / drug therapy
Hallucinations / physiopathology*
Hallucinations / psychology
Humans
Hypnotics and Sedatives / therapeutic use*
Lorazepam / therapeutic use*
Male
Methocarbamol / adverse effects
Muscle Relaxants, Central / adverse effects
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / drug therapy
Pneumonia, Viral / physiopathology*
Pneumonia, Viral / psychology
SARS-CoV-2
Spasm / drug therapy

Substances

Anti-Bacterial Agents
Hypnotics and Sedatives
Muscle Relaxants, Central
Methocarbamol
Azithromycin
Lorazepam